Clinical Trial 47030

Tustin, CA 92780


Summary:

A Phase I, Single-dose, Parallel Group Study to Assess the Pharmacokinetics of Olorofim in Subjects with Hepatic Impairment


Qualified Participants Must:

• Be 18 to 70 Years Old
• Have a BMI between 18 and 35
• Have been diagnosed with liver issues or liver disease


Qualified Participants May Receive:

Up to $1850.00


Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.